Back to search

Inhibitory effect of clentiazem (TA-3090) on platelet aggregation -alone and in combination with aspirin or ticlopidine

Data up to Jan 2025

Published1994
Citations10
References34

Total Citations Per Year

Abstract

References (34)

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1962 • 4,273 citations

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

1975 • 3,075 citations

A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients

1989 • 1,209 citations

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1978 • 933 citations

THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE

1989 • 912 citations

Inhibition of platelet prostaglandin synthetase by oral aspirin.

1978 • 552 citations

Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin

1977 • 209 citations

Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.

1985 • 197 citations

Inhibition of Human Platelet Functions by Verapamil

1981 • 114 citations

Mode of Action of Ticlopidine in Inhibition of Platelet Aggregation in the Rat

1979 • 91 citations

Effects by nifedipine (Adalat®) on platelet function in vitro and in vivo

1981 • 86 citations

Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.

1983 • 67 citations

Effect of the Calcium-Entry Blocking Agent Nifedipine on Activation of Human Platelets and Comparison with Verapamil

1983 • 63 citations

Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.

1981 • 57 citations

Inhibition of human platelet function by verapamil

1982 • 55 citations

Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.

1983 • 50 citations

In vitro effect of the coronary vasodilator diltiazem on human and rabbit platelets

1978 • 41 citations

Platelets and Thrombosis in the Development of Atherosclerosis and Its Complications

1978 • 38 citations

Effects of diltiazem, dipyridamole, and their combination on hemostasis

1984 • 34 citations

Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.

1988 • 32 citations

Effects of oral diltiazem on platelet function: alone and in combination with “low dose” aspirin

1986 • 27 citations

Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.

1988 • 24 citations

The disposition of sodium fusidate in man.

1977 • 23 citations

Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.

1988 • 20 citations

A Thiazole Compound with Potential Antithrombotic Activity

1982 • 16 citations

Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation

1988 • 15 citations

Mechanism of action of clentiazem on human coronary artery and myocardium

1990 • 14 citations

Antiplatelet effects of oral diltiazem, propranolol, and their combination.

1987 • 13 citations

Clinically Significant Antiplatelet Effects of Calcium‐Channel Blockers

1986 • 12 citations

In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium

1990 • 9 citations

Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood

1991 • 8 citations

Studies on inhibition of human platelet response by diltiazem

1990 • 7 citations

Platelet Function in Thrombosis and Atherosclerosis

1978 • 6 citations

Inhibition of platelet aggregation by a new 1.5-benzothiazepine calcium antagonist, TA-3090

1990 • 2 citations

Cited By (0)

Loading...